dev.PILOTforPulmonary.orgdev.PILOTforPulmonary.orgdev.PILOTforPulmonary.org

 x 

0 Activities
0 Activities
  • No Saved Activities
  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar

    Search Education

    Latest Education

    No image set

    A Collaborative Approach to IPF Management

    No image set

    Practical Solutions to SSc-ILD Treatment

    No image set

    Post COVID-19 and Patients With and Without Pre-existing ILD

    Menu Ad
  • Register
  • Contact Us
  • Login

    Login

    Create an account
    • Forgot your password?

EXPLORE™

  1. Home
  2. Education
  3. Content Type
  4. EXPLORE™
  5. Format

 

Jointly Accredited Provider

Search

  • Credit Type
    • CME (AMA PRA Category 1 Credit)
    • MOC (Maintenance of Certification)
  • Disease Area
    • Alpha-1 Antitrypsin Deficiency (AATD)
    • Asthma
    • Bronchiectasis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19
    • Cystic Fibrosis (CF)
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Interstitial Lung Disease (ILD)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Nontuberculous Mycobacteria (NTM)
    • Pulmonary Hypertension (PH/PAH)
    • Radiology
    • Rheumatoid Conditions
  • Content Type
    • Animation
    • EXPLORE™
    • Interactive Cases
    • Podcast
    • Slides
    • Video
    • Webinar

Beyond Pulmonary

Browse over 450 CME/CE courses on FranceFoundation.com

VIEW ALL EDUCATION
  • Start
  • «
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • »
  • End
Page 24 of 38
Results 346 - 360 of 566
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
No image set
Understanding the Endocannabinoid System (Cystic Fibrosis)
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
No image set
COPD: Proper Inhaler Use
No image set
Gene Therapy for Treatment of Hemophilia: Other Strategies and Targets
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
  • Start
  • «
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • »
  • End
Page 24 of 38

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Copyright © 2024 The France Foundation All Rights Reserved.
The France Foundation | Privacy Policy | Terms of Use

Search

  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar
  • Register
  • Contact Us
  • Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
I accept